Drawing on the combined expertise of over 170 members, we assist early-stage, high-growth British companies to maximise their potential. We seek out brands with outstanding founders, contemporary relevance and the ability to scale in sizeable markets.
Wearisma helps brands and agencies understand, measure and optimise influencer marketing ROI.
High performance lightweight anti-theft technologies.
Patented, smart vaping solution designed to help smokers quit for good.
Patented fuel contamination elimination
MeetspaceVR is an urban theme park bringing best of class social VR experiences all under one roof.
Number of members in the network
Number of current portfolio companies
Number of industries invested in
TOTAL ADJUVO MEMBER INVESTMENT SINCE 2015
Total third-party investment introduced
TOTAL FUNDRAISE ROUNDS subscribed
estimated Number of jobs created by portfolio companies
Number of shareholder updates produced in 2024
Number of events for the network
Percentage of fundraises that have been follow on rounds
Number of strategic introductions made to the portfolio in 2024
Number of people FROM ADJUVO APPOINTED ONTO portfolio boards
“I was immediately impressed by the level of expertise and industry experience of the Adjuvo members who expressed interest in Kindred. They were hugely supportive during our fundraise and the members who invested share our ambitions for the future. We are delighted to have them as investment partners.”
“While most investors call themselves ‘value add’, having taken investment from and worked with Adjuvo for the past three years, I can truly say that they are the very definition of that statement. Adjuvo’s members bring industry leadership to the table giving access to opportunities that can accelerate any business they choose to invest in. I am proud and grateful to have them as shareholders.”
“Adjuvo has helped to extend my investment portfolio of early-stage companies and provides a useful platform for engaging with other investors and experienced business leaders.”
“Adjuvo has put together a great group of investors, but what is most exciting to me is the variety of interesting investment opportunities. I see early-stage opportunities that I would be unlikely to see elsewhere.”
The two principals have extensive legal and financial backgrounds - one practiced as a solicitor in private equity transactions and investment funds before becoming a partner and general counsel for an investment house. The other is a chartered accountant and management consultant by training, with many years experience consulting in a wide variety of industries.
Perlin Partners offer a business advisory service that draws on a combination of legal, business and financial expertise. They specialise in advising companies looking at raising funds, reorganising their corporate structures, facing regulatory issues, and managing a sale, merger or acquisition.
Perlin Partners help Adjuvo to execute members investments and undertake due diligence projects. They specifically advise on underlying corporate documents, areas for negotiation, corporate structures and other related issues.
Robert Quinn Advisory acts as principal to Adjuvo and supervises its regulated activity in the UK.
Thompson Taraz is a leading UK fund and investment services group incorporating third party fund management, depositary, administration, custodian, nominee and investment consulting services.
They have a twenty year track record and are currently involved in the management and/or administration of over 70 collective investment vehicles with hundreds of underlying investments and over 7,000 investors with a total gross asset value exceeding £2 billion. They currently have circa £1 billion under management, and a particular focus on venture capital, EIS, property, energy and debt investment structures.
Philip Hare & Associates LLP is a tax consultancy business which specialises in the Enterprise Investment Scheme (EIS), Seed EIS, Venture Capital Trusts (VCT) and Social Investment Tax Relief (SITR). They advise small and medium sized companies and their investors in respect of the tax relief available for investment, and the conditions that need to be met by both the company and the investor. They are in regular contact with specialists at HMRC discussing solutions to technical and administrative issues that arise from the schemes.
Chief Executive Officer, Co-Founder & Director
Mark is the Chief Executive Officer and Co-Founding Partner of Adjuvo.
Mark brings a wealth of knowledge and experience to the process of introducing capital to private companies. He has a 38 year track record spanning the financial markets and investment process.
He started his career in 1986 at County NatWest Securities. In 1991 he co-founded the Emerging Markets business at James Capel, before moving to Morgan Grenfell & Co (later part of Deutsche Bank) in 1993.
In 1997 Mark was appointed Managing Director and head of Emerging European Equities in London, as well as a member of the Equities Division Management Committee. In 2001 he joined the Equity Special Situations business in Deutsche Bank, which later established itself independently as asset manager Altima Partners LLP in 2004.
Mark has an MA in English Literature from Cambridge University.
Managing Director
Louis is responsible for managing relationships within the Adjuvo Syndicate. He facilitates the introduction of new investment opportunities to members, as well as managing the interaction with a number of the Syndicate’s portfolio companies. At the board he contributes to the overall strategy and wider business development of the company. Louis originally joined the Adjuvo team in 2015 as an Associate.
Prior to joining Adjuvo Louis worked for two years in both London and Singapore at Human Capital (the Commodity executive search specialist) and for two years at Goodman Masson. Louis has a BA in Geography from Kings College London.
Chief Financial Officer
James is the Chief Financial Officer of Adjuvo, which he joined in September 2022. He brings a wealth of knowledge and experience on the financial, regulatory, and operational issues faced by investment firms at all stages of their life cycle.
James qualified as a Chartered Accountant at Smith and Williamson in 1996. He then joined Baring Private Equity Partners, a global private equity group, where he became Group Chief Financial Officer. In 2005 he joined Altima Partners LLP, a London-based alternative investment manager, where he was a partner responsible for finance, compliance, and operations.
James has a BSc (Hons) in Economics and Econometrics from St Andrews University.
Chief Operating Officer
Henry is a Director and Company Secretary at Adjuvo. He is responsible for managing the end to end investment proccess and relationship with Adjuvo’s custodian and nominee, Thompson Taraz. He supports the team in the day to day operational aspects of compliance, regulatory projects and due diligence.
Since graduating with a BA in Geography and Economics from Durham University, Henry has worked for a Strategy Consultancy and as an Analyst at a FinTech start-up.
Investment Opportunities
Philip is responsible for overseeing all new investment opportunities at Adjuvo. He works closely with Charlotte to manage the syndicate’s deal flow, including the evaluation of investment opportunities, deal origination, due diligence, and analysis. He formally joined the Adjuvo team in February 2022 but was a member since 2019.
Prior to joining Adjuvo, he enjoyed a 30 year career as a Managing Director in the equity division of Bank of America Merrill Lynch, with a particular focus on disruptors and the businesses they were disrupting.
Investment Opportunities
Charlotte works with Philip to manage the syndicate’s deal flow. She is responsible for the evaluation of investment opportunities, deal origination, due diligence, and analysis. She supports internal decision making on all new investment opportunities. She joined Adjuvo in February 2021 as an Analyst.
Prior to joining Adjuvo, she was a Graduate Analyst at J.P. Morgan. She holds a MSt Distinction in History from the University of Oxford, and a Certificate in Venture Finance from Saïd Business School, Oxford. Charlotte is currently studying with the Newton Fellowship program.
Portfolio
Ollie is responsible for portfolio management, reporting and shareholder communications at Adjuvo. He joined the team in December 2021 as an Associate Director.
Prior to joining Adjuvo, he spent three years at Seedrs in the Investment Team managing multiple fundraises for early-stage private companies within the portfolio. Prior to this he spent two years at Funding Circle as an Analyst with a focus on risk assessment of SMEs seeking debt finance. He studied Theology at Bristol University.
Communications
Tania has spent the majority of her career working in Marketing, Communications, Corporate PR and Events at many well known British retailers including Asprey, Mappin & Webb, Watches of Switzerland, Arcadia Group and Selfridges.
In 2018, she founded her own Communications consultancy supporting in-house teams with their marketing, communications and digital content strategy. These include Lane Crawford in Hong Kong, GLAS eyewear in Sweden, and Larizia and Ambassador Theatre Group in the UK.
As a consultant, Tania supports the Adjuvo management team in the same way, with a key focus on building community among the portfolio companies, network activations, and membership engagement.
Director
Rupert is responsible for fostering and managing investor relations, guiding portfolio operations, and identifying and capitalising on growth opportunities both within the company and in the broader market. His role involves not only maintaining robust relationships with existing partners and investors but also expanding the company’s network by introducing new investment opportunities.
Prior to Adjuvo, Rupert spent over a decade on the west coast of the United States where he established an Innovation Lab for Publicis Groupe in Silicon Valley. During his tenure there, he played a pivotal role as Head of Social and Mobile for all North America. Following this, he served as Senior Vice President and Head of Growth for acclaimed entrepreneur and business leader Gary Vaynerchuk.
More recently he was recognized as one of the Top 20 Innovators in CRM and he scouts for a number of Venture and PE funds.
Operations and Finance
Sean joined Adjuvo in November 2022 as an Associate. He works closely with Henry and supports the end to end investment process and relationship with Adjuvo’s custodian and nominee, Thompson Taraz. He supports the team in the day-to-day operational aspects of compliance, regulatory projects, and due diligence.
Before joining Adjuvo, Sean worked as an operations analyst at Kneip, an industry leader in data management and reporting, and as a junior project manager at Insurtech start-up Symfos.
Sean holds a BA in History from the University of Manchester and a certificate in Venture Capital: Master Startup Funding and Investment Strategies from Imperial College Business School.
Chairman & Founding Shareholder
Ross has a number of company roles including: the Pension Insurance Corporation Investment Committee, Chairing Adjuvo, and Directorships at AYR and Cycle Pharmaceuticals. He was previously Chairman of Cambridge University Investment Management and a Director of ED&F Man and HgCapital. He is a Fellow of Robinson College, University of Cambridge.
Following an economics degree at Cambridge University, Ross qualified as a chartered accountant with Price Waterhouse London. He joined Swiss Bank Corporation International in 1987, Nomura in 1991, SG Warburg 1993, and Salomon Brothers in 1996 (where he was latterly the head of trading equities and equity derivatives, Asia Pacific). From 2006-2018 he served as Bursar at Robinson College Cambridge where he was also Senior Treasurer of the Gates Foundation.
Co-Founder & Director
Andrew is a Co-founding Partner of Adjuvo and has a twenty year track record within the Executive Search industry. He has built and led teams, as well as managed senior client relationships across the financial services sector. Specifically, his expertise covers; private equity, capital markets, private wealth management, asset management and global emerging markets.
Andrew co-founded Rice & Dore Associates in 1997. He started his career in Executive Search in 1994 and holds a BA in Business Studies from Sheffield Hallam University.
Board Director
Andrew was Chairman and Chief Executive Officer of PGIM Quant Solutions from 2017 to 2022. Prior to joining PGIM Quant Solutions, Andrew was an Executive Vice President at Affiliated Managers Group, Inc., responsible for managing the central global distribution platform.
He has held senior distribution positions including Head of the International Institutional Business at BlackRock and Merril Lynch Investment Managers.
Andrew holds a Master’s Degree in Mathematics from Trinity College, University of Cambridge.
Communications
Francesca joined Adjuvo in August 2022 as an Associate. She is responsible for building community among the portfolio companies, network activations, and membership engagement through communications and in-person events. She works closely with Louis to develop and execute on the wider business and investor relations strategy.
Prior to Adjuvo, Francesca worked as a Behavioural Science Research Analyst at a cyber security startup, in Business Development at a health startup, and as a Legal Assistant at Keystone Law.
Francesca holds a BSc in Psychology from the University of Bath and a certificate in Venture Capital: Master Startup Funding and Investment Strategies from Imperial College Business School.
Office Manager
Lily-Rose joined the team in September 2024 as Office Manager. She is responsible for diary management and creating a smooth-running office environment that supports Adjuvo's business operations.
Prior to joining Adjuvo, Lily-Rose was an Account Coordinator at the advertising agency, VCCP. She holds a BA (Hons) in Media, Journalism and Publishing from Oxford Brookes University.
CEO: Pawel Kisielewski
Investment: £4 million including third party investment introduced by Adjuvo
Date of Most Recent Investment: August 2024
CCm Technologies have developed a fertiliser, produced from organic waste streams, that is not only regenerative to the soil, but removes greenhouse gases from the air, without sacrificing crop yield or affordability.
It is the only fertiliser that has been certified carbon negative by the Carbon Trust which is of vital importance to the many food and beverage companies who need to be able to verify and provide their supply chain’s carbon footprint data under Scope 3 emissions.
CEO: David Glover
Adjuvo Investment: £4.6 million
Date of Most Recent Investment: May 2024
Exceptionally strong, thin and light, Sandwich Plate System, SPS®, is a patent-protected structural composite material that can replace stiffened steel and structural concrete. This seemingly simple material is unique and used for maritime and offshore life extension and replacing ageing bridge and stadia infrastructure.
CEO: George Panton
Adjuvo Investment: £145k
Date of Most Recent Investment: February 2024
Boardforms offers board evaluation software to boards of directors.
"There should be a formal and rigorous annual evaluation of the performance of the board, its committees, the chair and individual directors" (UK Corporate Governance Code 2018).
The company refines the board evaluation process by producing an actionable report, leveraging AI.
Adjuvo Investment: £800k
Date of Most Recent Investment: December 2023
Javelo is a clinician-led healthcare technology company based in Scotland.
The company develops patent-protected solutions to improve safety and comfort for patients receiving intravenous therapy or haemodialysis.
The company’s technology is informed by the needs of patients and clinicians, delivering products that are effective, affordable and sustainable.
Adjuvo Investment: £2.4 million
Date of Most Recent Investment: August 2023
The Curators are on a mission to build the UK’s leading functional savoury snacks brand for modern active consumers, creating products with bold flavour and big nutrition.
The company has developed an innovative range of premium snacks that are light, crunchy and packed full of protein, underpinned by a distinctive and striking lifestyle brand.
CEO: Slava Kremerman
Adjuvo Investment: £21 million
Date of Most Recent Investment: March 2024
Zen Educate is a streamlined technology platform matching schools and supply teachers with a presence in both the UK and the US. Instead of using expensive and traditional agencies, schools can book supply teachers through Zen’s simple online platform.
By doing so, schools pay half the fees of a traditional agency and supply teachers get
paid up to 30% more for roles that are algorithmically better matched for both parties. All while cutting down on administrative hassle.
CEO: Aaron Simpson
Adjuvo Investment: £6.8 million
Date of Most Recent Investment: December 2023
Kindred is transforming e-commerce transactions into a force for good, without changing the way that people shop online.
This is achieved via the company's patented technology that integrates with browsers and apps to provide end users with discount and cash-back offers.
CEO: Ean Brown
Adjuvo Investment: £1.7 million
Date of Most Recent Investment: April 2024
Skarper has developed world's first, click on, and click off, patented device that converts the majority of bicycles ever manufactured into premium quality electric bikes, and back again, in less than five minutes.
It’s designed to be effortlessly removable, allowing the consumer to choose if they would like an electric bike or a standard bicycle at any given moment.
CEO: Neil Barron
Adjuvo Investment: £1.7 million
Date of Most Recent Investment: July 2023
'The best bike lock on the planet'
In Sept 2022, LITELOK X launched a range of lightweight D-locks that are armoured with Barronium™: a new composite technology, which offers unparalleled resistance to angle grinders.
After having several bikes stolen on the streets of London, Founder and CEO, Neil, felt determined to ensure that customers stay one step ahead in safeguarding their prized possessions.
Founder: Tom Lipinski
Adjuvo Investment: £1.5 million
Date of Most Recent Investment: September 2023
A first of its kind, Q-Bot is a Robotics as a Service solution for underfloor insulation. With 36 patents granted globally, they have developed small remote-controlled robots that can go underneath floorboards with ease – precision spraying insulating foam to everywhere required and permitted.
Its technology is both award winning and fully accredited, having successfully insulated circa 3,500 homes to date. The company is the default market leader in a hitherto untapped market worth £140 billion.
CEO: Isabella West
Adjuvo Investment: £716k
Date of Most Recent Investment: June 2023
Zoa Rental provide white-label technology that powers pay-per-wear fashion for retailers. They remove the complications of rental by providing the technology, data, logistics, and operations behind this offering – all via a SaaS model.
The company has developed a ‘smart rental button’ that fully integrates rental into a brand’s existing website for the first time, enabling retailers to launch their own-brand rental service.
CEO: Tash Grossman
Adjuvo Investment: £1.1 million
Date of Most Recent Investment: May 2024
Slip is a retail technology company that recognises receipts as one of the most under-appreciated assets in the retail world.
The business is on a mission to re-engineer receipts from a proof of purchase, which signifies the end of a customer journey, to a tool that helps retailers to better understand, re-engage, and reward their customers after leaving the store.
Whilst most investors call themselves “value-add”, having taken investment from and worked with Adjuvo for the past year, I can truly say that they are the very definition of that statement. Adjuvo has members who are leaders of practically every industry, and provide access to opportunities that can truly accelerate any business they choose to invest in. I am proud and grateful to have them as shareholders.
CEO: Hannah Chappatte
Adjuvo Investment: £1.6 million
Date of Most Recent Investment: November 2023
Hybr is a curated rental platform for first-time renters offering everything they need in one place, whilst ensuring landlords can fill vacancies quickly with pre-vetted young tenants.
The company has already supported over 25,000 students in their property search, has partnered with 20 UK universities, and has recently onboarded the likes of Touchstone and Greystar to its landlord portfolio.
CEO: Jenny Tsai
Adjuvo Investment: £2.3 million
Date of Most Recent Investment: March 2023
WeArisma’s data works to drive better choices and higher impact for every dollar spent on influencer marketing. The platform enables brands and their marketing agencies to forecast, measure, and optimize their influencer marketing performance and global competitive positioning.
The company has become of interest to financial services institutions, building ESG indicators to understand the social credit risk of influencer marketing.
CEO: Thom Groot
Adjuvo Investment: £500k
Date of Most Recent Investment: August 2022
The Electric Car Scheme makes it easier for people to adopt electric cars by cutting the cost by 30-60% and taking out the complexity of getting a car through salary sacrifice. It’s like the Cycle to Work scheme – only better!
You and your team can switch to drive any electric car through subscription or lease and include maintenance, charge point installation, and car insurance via the scheme.
CEO: Max Lytle
Adjuvo Investment: £6.6 million
Date of Most Recent Investment: September 2023
FuelActive helps operators of diesel engines save fuel and reduce emissions by supplying the cleanest fuel available to the engine. Extensive trials on heavy goods vehicles have proven a ~3-5% fuel efficiency improvement, with a corresponding CO2 reduction.
The company holds world-wide patents, is ISO 9001, 14001 and 45001 accredited, and won ‘Innovation of the Year’ at the International Business Awards. Sectors include Mining, Transportation, Construction and Rail.
CEO: Jonathan O’Halloran
Adjuvo Investment: £15 million
Date of Most Recent Investment: August 2022
QuantuMDx is a progressive MedTech company passionate about empowering the world to control disease and reduce suffering. The company solves real-world diagnostic problems by creating multiplex molecular solutions for the Point of Need.
Q-POC™ is a rapid, portable, sample to answer multiplex PCR device. It has been designed for use in a range of real-world settings, such as hospitals, clinics, pharmacies and dentists, providing accurate PCR results.
Founder: Francois Barou
CEO: Ian Murison
Adjuvo Investment: £4.8 million
Date of Most Recent Investment: February 2023
AYR is a UK technology company innovating for a nicotine-free future. The combination of its proprietary AYR vaporiser solutions, its licensed global IP portfolio and its unique know-how offers millions of smokers a pathway to reduce both their tobacco and nicotine consumption.
CEO: Steve Pomfret
Adjuvo Investment: £1.4 million
Date of Most Recent Investment: June 2023
Cygnetise is an authorised signatory management platform that allows customers to manage, share, and validate signatory data using blockchain technology. The company is on a mission to become the global standard for organisations, corporations and banks to maintain, record, and securely share their authorised signatory lists.
Cygnetise is not an e-signature application, but a real-time record management system for authorised signatories. The business already counts 59 customers, including the likes of Societe Generale, SoftBank, Investec, Stonehage Fleming and PwC.
CEO: John Lilley
Adjuvo Investment: £1.4 million
Date of Most Recent Investment: July 2024
MeetSpaceVR brings the best socially immersive virtual reality experiences into one arena.
With 7 venues, including in Victoria Centre Nottingham and the Utilita Arena Birmingham, MeetSpaceVR offers Arena Scale Free Roam VR, VR escape rooms, and VR Arcade games.
The company is the only UK provider of the world leading Zero Latency free roam multiplayer VR experience.
CEO: Ivan Mazour
Adjuvo Investment: £4.5 million
Date of Most Recent Investment: November 2021
Ometria is a customer data and marketing platform that combines profile unification and predictive intelligence with cross-channel marketing. The company helps retailers increase customer loyalty and repeat purchases by sending personalised messages throughout the customer journey.
The company is trusted by global fast-growing retail brands, such as Sephora and Hotel Chocolat.
Whilst most investors call themselves “value-add”, having taken investment from and worked with Adjuvo for the past year, I can truly say that they are the very definition of that statement. Adjuvo has members who are leaders of practically every industry, and provide access to opportunities that can truly accelerate any business they choose to invest in. I am proud and grateful to have them as shareholders.
We have been supported by Adjuvo since 2016. They have introduced a wide range of leading investors, but have also built an active and valuable relationship with me and my team – in recent weeks they have been involved at the heart of our Covid-19 response.
There are a lot of angels introduced to us through Adjuvo who have a real understanding of how the marketing landscape is shifting. You really need those innovators who have made it a really great experience. The team have been tremendous in doing due diligence, talking to our clients, understanding why they value us, and then communicating that to the investors. It’s been fascinating and I’ve learned so much.